The Valley Desk

NCT01710332 · Interventional trial

The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy

Overall registry status Completed

Phase 2

Conditions Central Serous Chorioretinopathy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov